Proprietary AI analyst is now available

Ansell Valuation Multiples

Discover Ansell's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Schott Pharma, Haemonetics, Shandong Weigao Blood, Dentsply Sirona and more.

Ansell Overview

About Ansell

Ansell is a leading supplier of protective gloves for use in healthcare and industrial settings, earning approximately 55% of revenue and 50% of operating profit from the healthcare segment and the remainder from the industrial segment. The company holds a large number of patents, and the majority of sales come from its key branded product ranges. Ansell has a global manufacturing and distribution footprint and distributes via key partners as well as directly across more than 100 countries. In fiscal 2025, Ansell earned 46% of revenue in North America, 31% from Europe, Middle East, and Africa, 14% across Asia-Pacific, and the remaining 10% in Latin America.


Founded

1920

HQ

Australia

Employees

15.7K

Website

ansell.com

Financials (LTM)

Revenue: $2B
EBITDA: $393M

EV

$4B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Ansell Financials

Ansell reported last 12-month revenue of $2B and EBITDA of $393M.

In the same LTM period, Ansell generated $898M in gross profit, $393M in EBITDA, and $205M in net income.

Revenue (LTM)


Ansell P&L

In the most recent fiscal year, Ansell reported revenue of $2B and EBITDA of $358M.

Ansell is profitable as of last fiscal year, with gross margin of 41%, EBITDA margin of 18%, and net margin of 10%.

See analyst estimates for Ansell
LTMLast FY202320242025202620272028
Revenue$2B$2B$2B$2B$2B
Gross Profit$898M$825M$621M$725M$862M
Gross Margin43%41%38%40%42%
EBITDA$393M$358M$239M$231M$327M
EBITDA Margin19%18%15%13%16%
EBIT Margin15%14%6%5%10%
Net Profit$205M$200M$112M$89M$153M
Net Margin10%10%7%5%8%
Net Debt-$461M---

Financial data powered by Morningstar, Inc.

Ansell Stock Performance

Ansell has current market cap of $3B, and enterprise value of $4B.

Market Cap Evolution


Ansell's stock price is $20.98.

Ansell share price increased by 4.6% in the last 30 days, and decreased by 2.6% in the last year.

Ansell has an EPS (earnings per share) of $1.41.

See more trading valuation data for Ansell
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$4B$3B1.4%4.6%3.6%-2.6%$1.41

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Ansell Valuation Multiples

Ansell trades at 1.7x EV/Revenue multiple, and 9.0x EV/EBITDA.

See NTM and 2027E valuation multiples for Ansell

EV / Revenue (LTM)


Ansell Financial Valuation Multiples

As of June 18, 2026, Ansell has market cap of $3B and EV of $4B.

Ansell has a P/E ratio of 14.5x.

LTMLast FY202320242025202620272028
EV/Revenue1.7x1.8x2.2x2.0x1.7x
EV/EBITDA9.0x9.9x14.9x15.3x10.8x
EV/EBIT11.2x12.5x36.1x42.8x16.6x
EV/Gross Profit4.0x4.3x5.7x4.9x4.1x
P/E14.5x14.8x26.4x33.3x19.3x
EV/FCF17.7x20.4x22.0x18.7x19.1x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Ansell Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Ansell Margins & Growth Rates

Ansell grew revenue by 4% and EBITDA by 10% in the last fiscal year.

In the most recent fiscal year, Ansell reported gross margin of 41%, EBITDA margin of 18%, and net margin of 10%.

See estimated margins and future growth rates for Ansell

Ansell Margins

Last FY202420252026202720282029
Gross Margin41%40%42%43%
EBITDA Margin18%13%16%19%
EBIT Margin14%5%10%15%
Net Margin10%5%8%10%
FCF Margin9%10%9%10%

Ansell Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth4%11%13%4%
Gross Profit Growth9%17%19%7%
EBITDA Growth10%(3%)42%22%
EBIT Growth12%(16%)158%50%
Net Profit Growth3%(21%)72%35%
FCF Growth16%18%(2%)17%

Data powered by FactSet, Inc. and Morningstar, Inc.

Ansell Operational KPIs

Ansell's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.

Ansell's Rule of 40 is 23% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Ansell's Rule of X is 29% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Ansell
LTMLast FY202320242025202620272028
Rule of 4023%23%---
Bessemer Rule of X29%29%---
Revenue per Employee-$0.1M---
Opex per Employee-$0.0M---
S&M Expenses to Revenue-32%28%31%31%
Opex to Revenue-36%32%35%35%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Schott Pharma2.6x2.6x9.2x9.6x
Haemonetics3.2x3.2x10.8x10.7x
Shandong Weigao Blood3.5x3.4x15.8x15.8x
Dentsply Sirona1.1x1.1x6.2x6.5x
Chengzhi1.2x-15.0x-
Inner Mongolia Furui Medical Science6.4x5.8x22.6x23.2x
Sotera Health5.5x5.3x10.7x10.4x
Stevanato Group3.7x3.5x14.5x13.7x

This data is available for Pro users. Sign up to see all Ansell competitors and their valuation data.

Start Free Trial

Acquisitions by Ansell

Ansell has acquired 4 companies to date.

Last acquisition by Ansell was on April 8th 2024. Ansell acquired Kimberly-Clark (personal protective equipment unit) for $640M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Ansell

Kimberly-Clark (personal protective equipment unit)
Ringers Gloves
Digitcare Corporation
Nitritex
Description
-
Ringers Gloves is a safety equipment manufacturer specializing in impact-resistant gloves for oil and gas, construction, and industrial workers. Headquartered in Houston, Texas, it engineers padded backhand protection models like Powderhead and Static Line for mechanical hazards. Ringers Gloves distributes worldwide to energy and manufacturing sectors.
Digitcare Corporation is a provider of medical care services focused on podiatry and wound care. Operating clinics in New Jersey, it offers treatments for foot disorders, diabetic care, and surgical procedures.
Nitritex is a manufacturer of cleanroom consumables under the BioClean brand, including gloves, swabs, and wipers for semiconductor and pharmaceutical environments. Based in Hungerford, Berkshire, United Kingdom, the company produces sterile and non-sterile products certified to ISO Class 4 standards, minimizing particle and extractable contamination. Nitritex supplies facilities for OLED display production and bioprocessing in Asia and Europe.
HQ CountryUnited StatesUnited StatesUnited StatesUnited Kingdom
HQ City
-
Houston, TX
Los Angeles, CA
Newmarket
Deal Date8 Apr 20241 Feb 201931 Oct 201830 Jan 2017
Valuation$640M$70Mundisclosed$56M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Ansell acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Ansell

When was Ansell founded?Ansell was founded in 1920.
Where is Ansell headquartered?Ansell is headquartered in Australia.
How many employees does Ansell have?As of today, Ansell has over 15K employees.
Who is the CEO of Ansell?Ansell's CEO is Neil I. Salmon.
Is Ansell publicly listed?Yes, Ansell is a public company listed on Australian Securities Exchange.
What is the stock symbol of Ansell?Ansell trades under ANN ticker.
When did Ansell go public?Ansell went public in 1985.
Who are competitors of Ansell?Ansell main competitors include Schott Pharma, Haemonetics, Shandong Weigao Blood, Dentsply Sirona, Chengzhi, Inner Mongolia Furui Medical Science, Sotera Health, Stevanato Group, BioLife Solutions, Sopharma.
What is the current market cap of Ansell?Ansell's current market cap is $3B.
What is the current revenue of Ansell?Ansell's last 12 months revenue is $2B.
What is the current revenue growth of Ansell?Ansell revenue growth (NTM/LTM) is 4%.
What is the current EV/Revenue multiple of Ansell?Current revenue multiple of Ansell is 1.7x.
What is the current EBITDA of Ansell?Ansell's last 12 months EBITDA is $393M.
What is Ansell's EBITDA margin?Ansell's last 12 months EBITDA margin is 19%.
What is the current EV/EBITDA multiple of Ansell?Current EBITDA multiple of Ansell is 9.0x.
What is the current FCF of Ansell?Ansell's last 12 months FCF is $201M.
What is Ansell's FCF margin?Ansell's last 12 months FCF margin is 10%.
What is the current EV/FCF multiple of Ansell?Current FCF multiple of Ansell is 17.7x.
How many companies Ansell has acquired to date?As of June 2026, Ansell has acquired 4 companies.
In how many companies Ansell has invested to date?Ansell hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Ansell

Lists including Ansell

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial